Centre for Human Drug Research
Business Services · Netherlands · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Zernikedreef 8, Leiden, South Holland, 2...Phone Number
+31 715246400Website
www.chdr.nlRevenue
$48.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Centre for Human Drug Research
CHDR is an independent institute based in Leiden, the Netherlands, specializing in innovative early-phase clinical drug research across various therapeutic areas including neurology, immunology, and dermatology. The company offers comprehensive trial services, supporting clients from study design to final clinical study reports, while utilizing state-of-the-art facilities for maximum efficiency. With over three decades of experience, CHDR also emphasizes education in clinical pharmacology for students and healthcare professionals. Their mission is to advance the boundaries of clinical drug development through scientific excellence.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Centre for Human Drug Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Centre for Human Drug Research
Check if Centre for Human Drug Research has recently received funding, and reach out quickly before it becomes old news!
Centre for Human Drug Research, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Centre for Human Drug Research launches new products
Check out if Centre for Human Drug Research is spiking on competitors!
Earning: See what the market has to say on Centre for Human Drug Research recently announced quarterly report
Click to see if Centre for Human Drug Research had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Centre for Human Drug Research has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Centre for Human Drug Research is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Centre for Human Drug Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Centre for Human Drug Research.
Centre for Human Drug Research Tech Stack
A closer look at the technologies used by Centre for Human Drug Research
Most Recent Scoops
Hiring Plans
Centre for Human Drug Research has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Centre for Human Drug Research has more open roles in Human Resources than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Centre for Human Drug Research has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Windows Virtual Desktop (WVD), Microsoft Windows PowerShell, Microsoft Active Directory, R, Microsoft Azure Active Directory, Microsoft Azure, and Informatica. Areas of expertise include: System Optimization, Custom Backend, Relational Databases, Java (Programming Language), Interdisciplinary Collaboration, Azure DevOps, and FlutterFlow.
Hiring Plans
Open Position
Hiring Plans
Hiring Plans
Centre for Human Drug Research News & Media
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke study data at the Interdisciplinary Conference on Psychedelic Research being held June 6-8, 2024 in HaaAnebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse (the “Company” or “Anebulo”), today announced that it will be giving an investor presentation at the H.C. Wainwright 25th Annual Global Investment Conference, from September 11 to September 13. In addition, the Company announced the acceptance of three presentations aAnebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Centre for Human Drug Research
Sign Up For FreeTo access detailed company insights
CHDR is an independent institute based in Leiden, the Netherlands, specializing in innovative early-phase clinical drug research across various therapeutic areas including neurology, immunology, and dermatology. The company offers comprehensive trial services, supporting clients from study design to final clinical study reports, while utilizing sta... Read More
